| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/22/2014 | CA2589192C Phenyl-piperazin methanone derivatives |
| 04/17/2014 | WO2014059333A1 Compounds that modulate intracellular calcium |
| 04/17/2014 | WO2014059185A1 Amino - dihydrothiazine and amino - dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use |
| 04/17/2014 | WO2014058037A1 Pyrone compounds and herbicides comprising the same |
| 04/17/2014 | WO2014057498A2 Process for the preparation of cobicistat intermediates |
| 04/17/2014 | WO2014057435A1 Orexin receptor antagonists which are [ortho bi (hetero )aryl]-[2-(meta bi (hetero )aryl)-pyrrolidin-1-yl]-methanone derivatives |
| 04/17/2014 | WO2014056938A1 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
| 04/17/2014 | WO2014056771A1 New pyrrolidine derivatives and their use as acetyl-coa carboxylase inhibitors |
| 04/17/2014 | WO2013064461A3 Compounds with nematicidal activity |
| 04/17/2014 | US20140107161 Insecticidal compounds based on arylthioacetamide derivatives |
| 04/17/2014 | US20140107149 Parasiticidal dihydroisoxazole compounds |
| 04/17/2014 | US20140107132 Substituted pyridine compounds for inflammation and immune-related uses |
| 04/17/2014 | US20140107125 Hydrazonopyrazole derivatives and their use as therapeutics |
| 04/17/2014 | US20140107116 Benzothiazole derivatives for the treatment of diabetes |
| 04/17/2014 | US20140107109 Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of use |
| 04/17/2014 | US20140107100 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture |
| 04/17/2014 | US20140107097 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| 04/17/2014 | US20140107096 HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt |
| 04/17/2014 | US20140107094 METHYLENE LINKED QUINOLINYL MODULATORS OF RORyt |
| 04/17/2014 | US20140107073 GDF-8 Inhibitors |
| 04/16/2014 | EP2719696A1 Novel kinase inhibitors |
| 04/16/2014 | EP2719693A1 Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound |
| 04/16/2014 | EP2719691A1 Benzothiazinethione derivatives and their preparative methods and uses |
| 04/16/2014 | EP2718290A2 Compositions and methods for modulating a kinase |
| 04/16/2014 | EP2718289A1 Novel insecticides |
| 04/16/2014 | EP2718284A1 TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS |
| 04/16/2014 | EP2718281A1 Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity |
| 04/16/2014 | EP2718279A1 Novel compounds as modulators of gpr-119 |
| 04/16/2014 | EP2718267A1 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 04/16/2014 | EP2718266A1 Pyridin- 2 -amides useful as cb2 agonists |
| 04/16/2014 | EP2717697A1 Active compound combinations |
| 04/16/2014 | CN103732593A Quinazoline-2,4-dione derivatives |
| 04/16/2014 | CN103724342A New antifungal drug compound as well as composition thereof and use |
| 04/16/2014 | CN103724341A Preparation method of ziprasidone hydrochloride and key intermediate thereof |
| 04/16/2014 | CN103724340A Thiazoles derivatives containing benzo oxygen-containing heterocyclic structure, and preparation method thereof |
| 04/16/2014 | CN103724339A Crystal forms of dihydropyrimidine derivatives |
| 04/16/2014 | CN103724338A Thiazoles derivatives containing naphthalene ring and pyrazoline structure, and preparation method thereof |
| 04/16/2014 | CN103724337A Pyrazoline derivatives containing naphthalene ring and thiazolinone structure, and preparation method thereof |
| 04/16/2014 | CN103724328A Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd |
| 04/16/2014 | CN103724322A Androgen receptor modulators and uses thereof |
| 04/16/2014 | CN103724319A Preparation method and purifying and extracting method for benzothiophene compounds |
| 04/16/2014 | CN102803250B 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17 |
| 04/16/2014 | CN102633709B Main luminophor material and organic light emitting diode containing same |
| 04/16/2014 | CN102574836B Aminopyrazole derivative |
| 04/16/2014 | CN102369195B Autotaxin inhibitors |
| 04/16/2014 | CN102105934B Coloring matter for optical information recording medium and optical information recording medium |
| 04/16/2014 | CN102066366B Novel substituted pyridin-2-ones and pyridazin-3-ones |
| 04/16/2014 | CN101948466B Asymmetric heterocyclic ring substituent urea compound and preparation method and application thereof |
| 04/16/2014 | CN101591332B Compound based on 4-phenyl-6-(2, 2, 2-trifluoro-1-phenylethoxy) pyridine and application method thereof |
| 04/15/2014 | US8697911 Rho kinase inhibitors |
| 04/15/2014 | US8697878 Thiazolyl oxime ethers and hydrazones as crop protection agents |
| 04/15/2014 | US8697870 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 04/15/2014 | US8697865 Cyclic amide derivative, and its production and use |
| 04/15/2014 | US8697728 Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM) |
| 04/15/2014 | US8697721 Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 04/15/2014 | US8697704 Hepatitis C virus inhibitors |
| 04/15/2014 | US8697698 Pyrazole compounds useful as protein kinase inhibitors |
| 04/15/2014 | US8697696 Triazole compounds II |
| 04/15/2014 | US8697685 Chemical compounds |
| 04/15/2014 | US8697683 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 04/15/2014 | CA2608319C Substituted spiro-compounds and the use thereof for producing medicaments |
| 04/15/2014 | CA2543858C Compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 04/10/2014 | WO2014055955A1 Gdf-8 inhibitors |
| 04/10/2014 | WO2014055634A1 Identification of small molecule inhibitors of jumonji at-rich interactive domain 1a (jarid1a) and 1b (jarid1b) histone demethylase |
| 04/10/2014 | WO2014055603A1 Process for the preparation of an hiv integrase inhibitor |
| 04/10/2014 | WO2014055548A1 Anti-fibrotic pyridinones |
| 04/10/2014 | WO2014053694A1 N-prop-2-ynyl carboxamide derivatives and their use as trpa1 antagonists |
| 04/10/2014 | WO2014053666A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/10/2014 | WO2014053665A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 04/10/2014 | WO2014053210A1 Pyrrolidines |
| 04/10/2014 | US20140100364 Compounds Useful For Making HCV Protease Inhibitors |
| 04/10/2014 | US20140100250 Pyridyl aminopyridines as syk inhibitors |
| 04/10/2014 | US20140100223 Compounds and methods for the treatment of isocitrate dehydrogenase related diseases |
| 04/10/2014 | US20140100215 Methods of Using PI3K and MEK Modulators |
| 04/10/2014 | US20140100214 Heterocyclic compounds and uses thereof |
| 04/10/2014 | US20140100213 Triazolones as fatty acid synthase inhibitors |
| 04/10/2014 | US20140100211 New pyrrolidine derivatives, pharmaceutical compositions and uses thereof |
| 04/10/2014 | US20140099333 Pyrrolidinone derivatives as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders |
| 04/09/2014 | EP2716636A1 Cyclic amide derivative |
| 04/09/2014 | EP2716635A1 Compounds which selectively modulate the CB2 receptor |
| 04/09/2014 | EP2714685A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/09/2014 | EP2714684A1 Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/09/2014 | EP2714683A2 Amorphous ritonavir co-precipitated |
| 04/09/2014 | EP2714682A1 Novel tetrahydroisoquinoline compounds for use in the diagnosis and treatment of neurodegenerative diseases |
| 04/09/2014 | EP2714680A1 Heterocyclic autotaxin inhibitors and uses thereof |
| 04/09/2014 | EP2714678A1 Imidazole derivatives |
| 04/09/2014 | EP2714668A1 Thiazole derivatives |
| 04/09/2014 | EP2714654A1 4-aryl-n-phenyl-1,3,5-triazin-2-amines containing a sulfoximine group |
| 04/09/2014 | CN103717595A Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives |
| 04/09/2014 | CN103717594A TRPV1 antagonists including dihydroxy substituent and uses thereof |
| 04/09/2014 | CN103717593A Compositions and methods for modulating a kinase |
| 04/09/2014 | CN103717591A Oxazole and thiazole derivatives as selective protein kinase inhibitors (c-kit) |
| 04/09/2014 | CN103717589A Compounds for the treatment and prophylaxis of respiratory syncytial virus disease |
| 04/09/2014 | CN103717588A Novel pyrazole derivative |
| 04/09/2014 | CN103717586A Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/09/2014 | CN103709156A Dasatinib polymorph medicine and preparation method thereof |
| 04/09/2014 | CN103709151A Spiro compounds adopted as hepatitis C inhibitor, and applications of spiro compounds in preparation of drugs |
| 04/09/2014 | CN103709129A Synthesis and application of diethylamino coumarin dye sensitizer |
| 04/09/2014 | CN103709097A 1,3-substituted carbamide or thiourea compound, preparation method thereof, pharmaceutical composition and application |
| 04/09/2014 | CN103709093A Combined-ring-containing pleuromutilin antibiotics |